Allstate Corporation’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,907
Closed -$525K 711
2021
Q4
$525K Sell
2,907
-1,528
-34% -$265K 0.01% 667
2021
Q3
$658K Sell
4,435
-540
-11% -$82.7K 0.03% 437
2021
Q2
$753K Sell
4,975
-441
-8% -$61.4K 0.03% 395
2021
Q1
$703K Hold
5,416
0.02% 425
2020
Q4
$650K Sell
5,416
-1,413
-21% -$139K 0.02% 396
2020
Q3
$510K Buy
6,829
+190
+3% +$13.2K 0.02% 416
2020
Q2
$469K Sell
6,639
-170
-2% -$11.6K 0.02% 453
2020
Q1
$447K Buy
6,809
+3,467
+104% +$276K 0.02% 384
2019
Q4
$273K Buy
+3,342
New +$256K 0.01% 552

Other funds holding OMCL

Allstate Corporation's OMCL Position: Q1 2022 in Review

Allstate Corporation sold out of Omnicell (OMCL) in Q1 2022, closing a stake of 2,907 shares — an estimated $525K sold.

Allstate Corporation first reported a position in OMCL in Q4 2019 and held it in 9 quarters. The position peaked at $753K in Q2 2021. 396 funds tracked by Wall St. Rank hold OMCL as of Q1 2022.

  • Allstate Corporation reported no remaining Omnicell position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 2,907 Omnicell shares in Q1 2022, an estimated $525K.
  • Allstate Corporation first reported a position in Omnicell in Q4 2019 and held it in 9 quarters.
  • Allstate Corporation's Omnicell position peaked at $753K in Q2 2021.
  • 396 funds tracked by Wall St. Rank held Omnicell as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.